The initial public offering of Arian Kimia Tak Pharmaceutical and Cosmetic Company will take place on Wednesday this week on the Tehran Stock Exchange (TSE) with Mellat Investment Bank (MIB) as listing consultant and underwriter.
PR department of MIB reports that a total of 225 million of Arian Kimia Tak Pharmaceutical and Cosmetic Company shares, equal to 15% (12% for the public and 3% to investment funds), will be offered for price discovery on September 8, 2021, as the 582nd company listed by TSE.
The maximum shares to buy by every natural and legal individual is set to be 300 shares. Orders can be registered on September 8, 2021, and registration price rate is between 18, 819 and 23,000 Rials. Therefore, the maximum required cash for the initial offering would be 2,300,000 Rials.
It is noteworthy that this company comprises of six well-known brands, namely, My, Schon, Ellaro, Neuderm, Callista, and Note. Golrang Industrial Group is also a major shareholder of the company with 38.7% ownership. The key product group of Arian Kimia Tak Pharmaceutical and Cosmetic Company includes cosmetic and skin-care products, sunscreens, moisturizers, and hand and face creams, which are available in 90% of the company’s existing brands, i.e. My, Schon, Ellaro, Neuderm, Callista, and Note. This product group holds the largest market share among productions of the company.
